Ni Xiaying
From Lianhua Qingwen to ibuprofen to Merrill Lynch, the demand for these anti-cold and fever-reducing drugs has increased rapidly with the release of prevention and control measures. The previous requirement of showing the health code to purchase these drugs has also been cancelled, so there is a sudden emergence of A situation of short supply. Although the manufacturers have begun to organize production with all their strength, it is still difficult for everyone to get the medicine. On the one hand, the price of raw materials has soared to a high level, approaching the production capacity ceiling of upstream suppliers, and the prices of auxiliary materials and packaging are also rising; It is also hindered, and it will take some time to alleviate the gap between the supply and demand of medicine.
This article is reproduced from: https://www.fortunechina.com/jingxuan/25507.htm
This site is only for collection, and the copyright belongs to the original author.